Venlafaxine Hydrochloride
Product Images NDC 71921-173

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71921-173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Florida Pharmaceutical Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Venlafaxine-01 (Ff9008be 0609 415c 810f C2bbbbdf305e 01)

A scatter plot chart illustrating pharmacokinetic (PK) fold changes and 90% confidence intervals for venlafaxine when co-administered with various interacting drugs. The chart compares Cmax, AUC, and ODV parameters relative to reference values, with recommendations for clinical use such as dose adjustments or cautionary notes.*

FDA Label Image

Venlafaxine-02 (Ff9008be 0609 415c 810f C2bbbbdf305e 02)

A chart showing pharmacokinetic fold changes and recommendations for various interacting drugs with VENLAFAXINE HYDROCHLORIDE. It plots Cmax and AUC values relative to a reference, with categories including drugs like ethanol, diazepam, alprazolam, and others, alongside clinical recommendations such as dose adjustments or monitoring suggestions.*

FDA Label Image

Ff9008be-0609-415c-810f-c2bbbbdf305e-03 (Ff9008be 0609 415c 810f C2bbbbdf305e 03)

A scatter plot chart displaying fold change and 90% confidence intervals for venlafaxine pharmacokinetic parameters (Cmax, AUC, ODV) across various special populations, including hepatic impairment, renal impairment, CYP2D6 polymorphism, age, and gender. The chart includes dosage adjustment recommendations based on observed pharmacokinetic changes relative to a reference value.*

FDA Label Image

Ff9008be-0609-415c-810f-c2bbbbdf305e-04 (Ff9008be 0609 415c 810f C2bbbbdf305e 04)

Chemical structure diagram of venlafaxine hydrochloride showing its molecular arrangement, including a cyclohexanol group, a methoxybenzene ring, and an amine group.*

FDA Label Image

Ff9008be-0609-415c-810f-c2bbbbdf305e-05 (Ff9008be 0609 415c 810f C2bbbbdf305e 05)

Label for Venlafaxine HCl Extended-release Capsules, USP 37.5 mg, with a package count of 30 capsules. Label includes manufacturer details: Inventia Healthcare Limited, and labeler Florida Pharmaceutical Products, LLC. The label specifies storage conditions, usual dosage directions to consult prescribing information, and pharmacy dispensing instructions. Barcodes and NDC number 71921-172-33 are visible, along with the FPP logo.*

FDA Label Image

Ff9008be-0609-415c-810f-c2bbbbdf305e-06 (Ff9008be 0609 415c 810f C2bbbbdf305e 06)

Label for Venlafaxine HCl Extended-release Capsules, USP 75 mg, supplied in a 30 capsule package by Florida Pharmaceutical Products, LLC. The label includes dosage strength, pharmacist dispensing instructions, storage conditions, manufacturing details by Inventia Healthcare Limited, and a barcode. It also notes that the capsules contain venlafaxine hydrochloride equivalent to 75 mg of venlafaxine and that the product is sealed for protection.*

FDA Label Image

Ff9008be-0609-415c-810f-c2bbbbdf305e-07 (Ff9008be 0609 415c 810f C2bbbbdf305e 07)

Label for Venlafaxine HCl Extended-release Capsules, USP 150 mg by Florida Pharmaceutical Products, LLC. The label states a 30-capsule package, includes storage temperature instructions, pharmacist dispensing note, manufacturer details (Inventia Healthcare Limited), and barcodes. The label highlights the dosage strength and is designed for prescription use only.*

FDA Label Image

Ff9008be-0609-415c-810f-c2bbbbdf305e-08 (Ff9008be 0609 415c 810f C2bbbbdf305e 08)

VENLAFAXINE HYDROCHLORIDE cartridge packaging label from Florida Pharmaceutical Products, LLC. The label has black text on a white background but no visible dosage strength or form details on the image provided.*

FDA Label Image

Ff9008be-0609-415c-810f-c2bbbbdf305e-09 (Ff9008be 0609 415c 810f C2bbbbdf305e 09)

VENLAFAXINE HYDROCHLORIDE 1 mg tablet bottle from Florida Pharmaceutical Products, LLC. The white plastic bottle has a child-resistant cap and a label with active ingredient and dosage strength. The label includes storage instructions and a barcode.*

FDA Label Image

Ff9008be-0609-415c-810f-c2bbbbdf305e-13 (Ff9008be 0609 415c 810f C2bbbbdf305e 13)

VENLAFAXINE HYDROCHLORIDE tablet blister pack containing 10 scored tablets. The pack shows partial labeling in English, with tablets in a 2 by 5 arrangement. The labeler is Florida Pharmaceutical Products, LLC, as indicated on the carton insert visible underneath.*

FDA Label Image

Ff9008be-0609-415c-810f-c2bbbbdf305e-14 (Ff9008be 0609 415c 810f C2bbbbdf305e 14)

VENLAFAXINE HYDROCHLORIDE label from Florida Pharmaceutical Products, LLC showing the product name prominently. The label includes usage and safety instructions, an NDC code, and a barcode. The packaging design is primarily brown with white text areas, suitable for a pharmaceutical product container.*

FDA Label Image

Ff9008be-0609-415c-810f-c2bbbbdf305e-15 (Ff9008be 0609 415c 810f C2bbbbdf305e 15)

VENLAFAXINE HYDROCHLORIDE 37.5 mg capsule bottle label from Florida Pharmaceutical Products, LLC. The label includes the proprietary name, strength, dosage form as capsules, and directions for use. The bottle contains 100 capsules with a child's safety cap.*

FDA Label Image

Ff9008be-0609-415c-810f-c2bbbbdf305e-16 (Ff9008be 0609 415c 810f C2bbbbdf305e 16)

VENLAFAXINE HYDROCHLORIDE 37.5 mg extended-release capsules, labeled by Florida Pharmaceutical Products, LLC. The packaging is a white and blue blister card containing 14 capsules arranged in two rows of seven. Each capsule is white and blue with imprint consisting of the letters 'VF' and the dosage strength '37.5 mg.'*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.